as on December 6, 2025 at 2:29 am IST
Day's Low
Day's High
1.91%
Downside
0.79%
Upside
52 Week's Low
52 Week's High
54.05%
Downside
10.01%
Upside
Check Ocular Therapeutix Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.7B
EPS (TTM)
-1.4167
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-9.65
Industry PE ratio
-0.4116938110749186
PEG Ratio
0EBITDA
-259.9M
Revenue (TTM)
55.8M
Profit Margin
0.00%
Return On Equity TTM
-81.83%
Track how Ocular Therapeutix Inc P/E has moved over time to understand its valuation trends.
Ocular Therapeutix Inc in the last 5 years
Lowest (-86.29x)
December 31, 2021
Today (-9.65x)
December 8, 2025
Industry (-0.41x)
December 8, 2025
Highest (-2.53x)
December 31, 2023
Today’s Price to Earnings Ratio: -9.65x
Compare market cap, revenue, PE, and other key metrics of Ocular Therapeutix Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $2.7B | -35.35% | -9.65 | 0.00% | |
| BUY | $43.5B | 418.42% | -16.34 | -264.83% | |
| BUY | $60.5B | 257.77% | 1431.62 | 1.36% | |
| BUY | $116.8B | 98.18% | 32.05 | 31.35% | |
| BUY | $76.1B | 44.5% | 17.21 | 32.13% |
The Ocular Therapeutix Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Ocular Therapeutix Inc investment value today
Current value as on today
₹1,37,012
Returns
₹37,012
(+37.01%)
Returns from Ocular Therapeutix Inc Stock
₹30,873 (+30.87%)
Dollar Returns*
₹6,139 (+6.14%)
Based on 14 analysts
85.71%
Buy
14.29%
Hold
0.00%
Sell
Based on 14 analysts, 85.71% of analysts recommend a 'BUY' rating for Ocular Therapeutix Inc. Average target price of $22.92
Get share price movements and forecasts by analysts on Ocular Therapeutix Inc.
What analysts predicted
45.07%UPSIDE
Target Price
$22.92
Current Price
$12.59
Analyzed by
14 Analysts
Target
$22.92
Ocular Therapeutix Inc target price $22.92, a slight upside of 45.07% compared to current price of $12.59. According to 14 analysts rating.
Search interest for Ocular Therapeutix Inc Stock has decreased by -66% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 02 October
Thu, 10:16 AM
-Ocular Therapeutix shares drop 6.7% after announcing $475 million share sale to fund clinical trials and infrastructure.
Thu, 03:22 PM
-Analyst reiterates Buy rating for Ocular Therapeutix, citing promising clinical trials and strategic advancements.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 10.69M → 14.54M (in $), with an average increase of 14.0% per quarter
Price Rise
![]()
In the last 3 years, OCUL stock has moved up by 355.8%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 995.0% return, outperforming this stock by 639.2%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 170.6% return, outperforming this stock by 139.8%
Profit Down
![]()
Netprofit is down for the last 5 quarters, -36.49M → -69.41M (in $), with an average decrease of 18.3% per quarter
| Organisation | Ocular Therapeutix Inc |
| Headquarters | 15 Crosby Drive, Bedford, MA, United States, 01730 |
| Industry | Health Technology |
| CEO | Dr. Pravin U. Dugel M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Barry Rubenstein M.S. | Chief Human Resources Officer |
Dr. Pravin U. Dugel M.D. | Executive Chairman, President & CEO |
Mr. Donald Notman Jr. | CFO, COO & Principal Accounting Officer |
Dr. Peter K. Jarrett Ph.D. | Chief Technical Officer |
Mr. William S. Slattery Jr. | Vice President of Investor Relations |
Mr. Todd D.C. Anderman J.D. | Chief Legal Officer & Corporate Secretary |
Mr. William H. Ransone II | Vice President of Global Sales & Marketing |
Mr. Steve Meyers | Chief Commercial Officer |
Dr. Jeffrey S. Heier M.D. | Chief Scientific Officer |
Dr. Peter K. Kaiser M.D. | Chief Development Officer |
Ocular Therapeutix Inc share price today is $12.59 as on at the close of the market. Ocular Therapeutix Inc share today touched a day high of $12.69 and a low of $12.35.
Ocular Therapeutix Inc share touched a 52 week high of $13.85 on and a 52 week low of $5.79 on . Ocular Therapeutix Inc stock price today i.e. is closed at $12.59,which is 9.10% down from its 52 week high and 117.63% up from its 52 week low.
Ocular Therapeutix Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Ocular Therapeutix Inc (OCUL) shares with as little as ₹90.066 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹900.66 in Ocular Therapeutix Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Ocular Therapeutix Inc share’s latest price of $12.59 as on December 6, 2025 at 2:29 am IST, you will get 0.7943 shares of Ocular Therapeutix Inc. Learn more about
fractional shares .
Ocular Therapeutix Inc stock has given -35.35% share price returns and 21.76% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?